The first vision-correction contact lens (CL) to relieve allergic eye itch has received approval from the Japanese Ministry of Health, Labour and Welfare.
Johnson & Johnson Vision’s Acuvue Theravision is a daily disposable CL containing ketotifen, an H1 histamine receptor antagonist for the prevention of itch associated with eye allergies. Dr Brian Pall, J&J’s director of clinical science, said that over 40% of people suffer from eye allergies which is problematic for those who wear contact lenses, particularly during high pollen-count seasons. "We're proud to bring forward a new contact lens that simultaneously provides vision correction and relief of allergic eye itch, without the need for allergy eye drops.”
